Chip Davis, president and CEO of the Generic Pharmaceutical Association (GPhA), announced this week that Dr. Robert Califf has received enough votes from the Senate Committee on Health, Education Labor and Pensions (HELP) in favor of his nomination as the new commissioner of the Food and Drug Administration (FDA). Read More »

In a recent blog post on the American Academy of Family Physicians (AAFP) website, board member John Bender reflected on the potential that telehealth offers for family medicine. Read More »

The National Institute of Allergy and Infectious Diseases has donated $5 million to fund 24 research projects designed to cultivate therapeutic alternatives to traditional antibiotics. Read More »

RxBenefits has announced that it will be the beneficiary of a sizeable investment from Great Hill Partners. Read More »

A recent survey done by Drug Topics has revealed that pharmacists saw a slight pay increase in 2015 and expect 2016 to yield the same results. Read More »

A new federal initiative announced by the Medicare Accountable Care Organization (ACO) will make the quality of care for patients more important than quantity of procedures administered. Read More »

A recent article in the Wall Street Journal as well as analyst commentary noted that Pfizer Inc., Amgen Inc., Allergan PLC and others have hiked up dozens of U.S. drug prices since December, with many of the increases at nearly 9 percent and 10 percent. Read More »

Pfizer recently announced it is teaming up with Adaptive Biotechnologies to help advance its growing immuno-oncology pipeline. Read More »

The Food and Drug Administration (FDA) is warning health-care professionals and patients that dosing errors have occurred when switching between two different oral formulations of Noxafil. Read More »

Pfizer Inc. announced last week that its Research and Development investment strategy will be expanded to include companies in the initial phases of scientific advancements. Read More »

The Safety Review Committee has approved DepoVax prophylactic Respiratory Syncytial Virus vaccine (DPX-RSV), developed by Immunovaccine Inc., for the next step in testing. Read More »

Acadia Pharmaceuticals this week appointed Jim Daly to its board of directors. Read More »

Allergan purchased medical dermatology and aesthetic medicine company Anterios for $90 million late last week in an effort to boost its neurotoxin line of products. Read More »

Sanofi and Regeneron Pharmaceuticals Inc. announced last week that the U.S. Food and Drug Administration (FDA) will review their Biologics License Application for sarilumab, an antibody that will help treat patients with moderate-to-severe rheumatoid arthritis. Read More »

Johnson & Johnson Health and Wellness Solutions has partnered with Plug and Play Tech Center to launch an accelerator dedicated to promoting healthy lifestyles. Read More »

Shareholders were offered $182 per share for McKesson Corp. common stocks on Dec. 15 by TRC Capital Corp. Read More »

Proxsys Rx, which develops and administers pharmacy-centric technology and services, has designed a software program to help qualifying hospitals stay compliant with the federal 340B program to distribute low-cost pharmaceuticals to underserved and indigent populations. Read More »

Takeda Pharmaceutical Co. said this week it is teaming up with French drugmaker Enterome to develop new treatments for gastrointestinal disorders. Read More »

Retired U.S. Army General and former chairman of the Joint Chiefs of Staff Martin E. Dempsey will speak during the 2016 NACDS Annual Meeting’s Business Program on April 19, in Palm Beach, Florida. Read More »

Novartis Pharmaceuticals revealed this week that it is collaborating with Qualcomm Life to develop the next generation of the Breezhaler inhaler for individuals with chronic obstructive pulmonary disease (COPD). Read More »